$1.10
0.065.77%
Last update: Nov 11, 8:46 AM
BioStem Technologies Inc
BSEMNASDAQ
BioStem Technologies fell 75.5% from $4.57 to $1.12, behind the S&P 500's +9.8%. Its worst day was Oct 19 (−26.3%), and its low came Nov 5 at $1.04.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
BioStem Technologies closed at its highest level of the year, 79.5% above where the year started.
+25.4% · S&P 500 +0.4%
BioStem Technologies shares rose 21.4%, while the S&P 500 rose 0.5%.
+21.4% · S&P 500 +0.5%
Story events cover the past 12 months · Times ET
EPS of $-0.52 was reported on $7.9M revenue.
−18.4% · S&P 500 +0.7%
BioStem Technologies shares fell 19.3%, while the S&P 500 fell 0.2%.
−19.3% · S&P 500 −0.2%
BioStem Technologies shares fell 26.3%, while the S&P 500 rose 0.4%.
−26.3%, the year's worst day · S&P 500 +0.4%
Where it ended: a close of $1.12 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 12, 2026 (EPS est. $-0.43, revenue est. $7.2M).
Nothing in the past 12 months.
All BSEM analyst actionsNothing in the past 12 months.
All BSEM dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BSEM and SPY from Benzinga historical bars. Not investment advice.
